Author:
Myers L.,Ireland M. J.,Viljoen B.,Goodwin B.
Abstract
Abstract
Purpose
Many people do not participate in mail-out bowel cancer screening programs due to difficulties using the screening kit. The current study investigated the ways the screening kit could be modified to improve usability.
Methods
1,109 people evaluated 15 different screening kit modifications. Participants reported on how these kit modifications would affect their screening barriers, their future screening intentions, and how much they would recommend that the modification is made to the current screening kit used the program. All responses were given via an online survey conducted between April and December of 2021.
Results
Seventeen percent of previous NBCSP non-participators indicated that a one-sample test would increase their intention to participate. Recommendation ratings demonstrated higher levels of support for modifications that included providing a barcode naming label (M = 9.06, 95% CI [8.81, 9.31]), having a larger diameter opening of the collection tube (M = 8.42, 95% CI [8.10, 8.74]), and highlighting the expiry date on the kit packaging (M = 8.59, 95% CI [8.29, 8.89]). There were lower levels of support for modifications that reduced the size of the packaging the kit is sent in (M = 6.47, 95% CI [6.09, 6.85]), removed branding from kit packaging (M = 5.98, 95% CI [5.57, 6.39]), and removed the information booklet that comes with the screening kit (M = 5.25, 95% CI [4.78, 5.72]).
Conclusion
These findings highlight multiple ways in which bowel cancer screening kits can be changed to increase usability for invitees of national bowel cancer screening programs. Findings have implications for all screening programs that use immunochemical-based bowel cancer screening kits.
Funder
University of Southern Queensland
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
2. Australian Institute of Health and Welfare (2021) Cancer in Australia 2021. Australian Institute of Health and Welfare. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2021/summary. Accessed 6 Dec 2021
3. Navarro M, Nicolas A, Ferrandez A, Lanas A (2017) Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol 23:3632
4. Australian Institute of Health and Welfare (2021) National Bowel Cancer Screening Program monitoring report 2021. AIHW, Canberra. https://www.aihw.gov.au/reports/cancer-screening/nbcspmonitoring-report-2021/summary
5. Lew J-B, St John DJB, Xu X-M, Greuter MJ, Caruana M, Cenin DR et al (2017) Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. Lancet Public Health 2:e331–e340